Ars Investment Partners, LLC Ascendis Pharma A/S Transaction History

Ars Investment Partners, LLC

$947 Million
Q4 2024

A detailed history of Ars Investment Partners, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Ars Investment Partners, LLC holds 265,480 shares of ASND stock, worth $34 Million. This represents 3.86% of its overall portfolio holdings.

Number of Shares

265,480

Previous 263,111 0.9%

Holding current value

$34 Million

Previous $39.3 Million 6.98%

% of portfolio

3.86%

Previous 4.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	BUY	$122.0 - $146.6 $289,018 - $347,295	2,369 Added 0.9%	265,480 $36.5 Million
Q3 2024 Oct 16, 2024	BUY	$113.0 - $153.43 $1.13 Million - $1.53 Million	9,972 Added 3.94%	263,111 $39.3 Million
Q2 2024 Jul 17, 2024	SELL	$121.07 - $153.67 $221,315 - $280,908	-1,828 Reduced 0.72%	253,139 $34.5 Million
Q1 2024 May 02, 2024	SELL	$123.45 - $159.4 $3.43 Million - $4.43 Million	-27,777 Reduced 9.82%	254,967 $38.5 Million
Q4 2023 Feb 14, 2024	SELL	$86.1 - $127.36 $273,281 - $404,240	-3,174 Reduced 1.11%	282,744 $35.6 Million
Q3 2023 Nov 13, 2023	SELL	$86.5 - $103.97 $340,983 - $409,849	-3,942 Reduced 1.36%	285,918 $26.8 Million
Q2 2023 Jul 11, 2023	BUY	$69.96 - $97.84 $3.56 Million - $4.97 Million	50,822 Added 21.26%	289,860 $25.9 Million
Q1 2023 Apr 05, 2023	BUY	$104.9 - $126.78 $43,743 - $52,867	417 Added 0.17%	239,038 $25.6 Million
Q4 2022 Jan 25, 2023	BUY	$99.42 - $131.97 $1.11 Million - $1.48 Million	11,194 Added 4.92%	238,621 $0
Q3 2022 Oct 07, 2022	BUY	$84.03 - $110.23 $5.93 Million - $7.77 Million	70,527 Added 44.95%	227,427 $23.5 Million
Q2 2022 Jul 15, 2022	BUY	$78.08 - $117.61 $1.47 Million - $2.22 Million	18,870 Added 13.67%	156,900 $14.6 Million
Q1 2022 May 16, 2022	SELL	$102.18 - $135.75 $167,881 - $223,037	-1,643 Reduced 1.18%	138,030 $16.2 Million
Q4 2021 Feb 11, 2022	BUY	$127.1 - $169.66 $2.4 Million - $3.2 Million	18,863 Added 15.61%	139,673 $18.8 Million
Q3 2021 Nov 05, 2021	BUY	$112.67 - $176.92 $5.02 Million - $7.88 Million	44,558 Added 58.44%	120,810 $19.3 Million
Q2 2021 Aug 06, 2021	BUY	$121.62 - $145.29 $143,998 - $172,023	1,184 Added 1.58%	76,252 $10 Million
Q1 2021 May 13, 2021	BUY	$124.92 - $173.33 $1.99 Million - $2.76 Million	15,932 Added 26.94%	75,068 $9.68 Million
Q4 2020 Feb 09, 2021	BUY	$151.2 - $182.76 $2.34 Million - $2.83 Million	15,467 Added 35.42%	59,136 $9.86 Million
Q3 2020 Nov 12, 2020	BUY	$134.29 - $154.32 $1.76 Million - $2.02 Million	13,098 Added 42.84%	43,669 $6.74 Million
Q2 2020 Aug 13, 2020	SELL	$110.87 - $156.01 $19,623 - $27,613	-177 Reduced 0.58%	30,571 $4.52 Million
Q1 2020 May 12, 2020	BUY	$97.01 - $145.11 $1.52 Million - $2.27 Million	15,669 Added 103.91%	30,748 $3.46 Million
Q4 2019 Feb 12, 2020	BUY	$91.45 - $139.12 $1.38 Million - $2.1 Million	15,079 New	15,079 $2.1 Million

Others Institutions Holding ASND

# of Institutions

243

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.15B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ars Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ars Investment Partners, LLC with notifications on news.

Account

Ars Investment Partners, LLC Ascendis Pharma A/S Transaction History